We like to keep our readers up to date on complex regulatory issues, the latest industry trends and updated guidelines to help you to solve a problem or make an informed decision.
Latest Blog posts
blog
Summary of FDA Advisory Committee on COVID-19 Vaccines (Oct 22)
On Oct. 22nd, the Vaccines and Related Biological Products Advisory Committee from FDA held a nine-hour virtual meeting (Advisory Committee Meeting) to…
blog
What are the Need-to-Know incentives associated with an Orphan Drug Designation (ODD)?
With a low prevalence, rare diseases affect six to eight percent of the population worldwide and therefore represent a global…
blog
New FDA Guidance on Multiple Function Device Products & Its Impact on Software as A…
While the original Apple Watch was a genuine consumer product with fitness tracking and health-oriented capabilities, the adjunct of the…
blog
New Guidance on Clinical Evaluation of Medical Device Software
The Medical Device Coordination Group (MDCG) recently published a new guidance entitled “Guidance on Clinical Evaluation (MDR) / Performance Evaluation…
blog
Advice on Non-clinical and Clinical Development for ATMPs from an Ex-CAT member
Gene Therapies and Cell-based products, referred to as Regenerative Medicine Advanced Therapy (RMAT) in the USA and as Advanced Therapy Medicinal…
blog
Expectations from Regulatory Agencies on Nitrosamine Impurities
On Friday, 27th March 2020, the European medicines regulatory network extended the deadline to complete an initial risk evaluation for…
blog
How to Successfully Manage The Challenges of Developing an ATMP
ATMPs (Advanced Therapy Medicinal Product), covering cell and gene therapy products, have a huge therapeutic potential to treat serious diseases.…
blog
The Microbiome Journey: Development of a Drug Product
In a wide range of therapeutic areas, recent studies have highlighted the link between microbial imbalance (dysbiosis) and the development…
Resources 